DNA immunization perturbs lipid metabolites and increases risk of atherogenesis

Journal of Proteome Research

Volumn 7, Issue 2, 2008, Pages 741-748

  Yang, Fu ^a   Yan, Shikai ^b   Wang, Fang ^a   He, Ying ^a   Guo, Yingjun ^a   Zhou, Qi ^a   Wang, Yue ^a   Zhang, Xiaoying ^a   Zhang, Weidong ^a,b   Sun, Shuhan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apolipoprotein; DNA immunization; Metabolomics; Proteomics; Sphingolipid

Indexed keywords

APOLIPOPROTEIN A1 PRECURSOR PROTEIN; CERAMIDE; DNA VACCINE; LIPID; PALMITOYLCARNITINE; PHYTOSPHINGOSINE; PROTEIN PRECURSOR; SPHINGANINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOGENESIS; LIVER; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; VACCINATION;

ANIMALS; ANTIBODIES; ATHEROSCLEROSIS; HEPATITIS B VACCINES; LIPID METABOLISM; MICE; MICE, INBRED C57BL; TANDEM MASS SPECTROMETRY; VACCINES, DNA;

MUS;

EID: 39749107447     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr700663q     Document Type: Article

References (33)

1. Davis, H. L.; Mancini, M.; Michel, M. L.; Whalen, R. G. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 1996, 14, 910-915.
2. Michel, M. L.; Davis, H. L.; Schleef, M.; Mancini, M.; Tiollais, P.; Whalen, R. G. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 5307-5311.
3. Conry, R. M.; Curiel, D. T.; Strong, T. V.; Moore, S. E.; Allen, K. O.; Barlow, D. L.; Shaw, D. R.; LoBuglio, A. F. Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients. Clin. Cancer Res. 2002, 8, 2782-2787.
4. Roy, M. J.; Wu, M. S.; Barr, L. J.; Fuller, J. T.; Tussey, L. G.; Speller, S.; Culp, J.; Burkholder, J. K.; Swain, W. F.; Dixon, R. M.; Widera, G.; Vessey, R.; King, A.; Ogg, G.; Gallimore, A.; Haynes, J. R.; Heydenburg Fuller, D. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 2000, 19, 764-778.
5. Zi, X. Y.; Yao, Y. C.; Zhu, H. Y.; Xiong, J.; Wu, X. J.; Zhang, N.; Ba, Y.; Li, W. L.; Wang, X. M.; Li, J. X.; Yu, H. Y.; Ye, X. T.; Lau, J. T.; Hu, Y. P. Long-term persistence of hepatitis B surface antigen and antibody induced by DNA-mediated immunization results in liver and kidney lesions in mice. Eur. J. Immunol. 2006, 36, 875-886.
6. Sheets, R. L.; Stein, J.; Manetz, T. S.; Duffy, C.; Nason, M.; Andrews, C.; Kong, W. P.; Nabel, G. J.; Gomez, P. L. Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts. Toxicol. Sci. 2006, 91, 610-619.
7. Jiang, L.; Qian, F.; He, X.; Wang, F.; Ren, D.; He, Y.; Li, K.; Sun, S.; Yin, C. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice. J. Gene Med. 2007, 9, 253-264.
8. Weeks, M. E.; Sinclair, J.; Butt, A.; Chung, Y. L.; Worthington, J. L.; Wilkinson, C. R.; Griffiths, J.; Jones, N.; Waterfield, M. D.; Timms, J. F. A parallel proteomic and metabolomic analysis of the hydrogen peroxide- and Sty1p-dependent stress response in Schizosaccharomyces pombe. Proteomics 2006, 6, 2772-2796.
9. Craig, A.; Sidaway, J.; Holmes, E.; Orton, T.; Jackson, D.; Rowlinson, R.; Nickson, J.; Tonge, R.; Wilson, I.; Nicholson, J. Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. J. Proteome Res. 2006, 5, 1586-1601.
10. Xiao-wen, H.; Shu-han, S.; Zhen-lin, H.; Jun, L.; Lei, J.; Feng-juan, Z.; Ya-nan, Z.; Ying-jun, G. Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting. Vaccine 2005, 23, 1649-1656.
11. Sun, S. H.; Wang, R. w.; Chen, R. W.; Yang, H. Molecular cloning of cDNA encoding immunodiagnostic antigen of cysticercosis. Chin. J. Parasitol. Parasitic Dis. 1997, 1, 5-20.
12. Li, D. A.; He, Y.; Guo, Y. J.; Wang, F.; Song, S. X.; Wang, Y.; Yang, F.; He, X. W.; Sun, S. H. Comparative proteomics analysis to annexin B1 DNA and protein vaccination in mice. Vaccine 2007, 25, 932-938.
13. Yang, F.; Yan, S. K.; He, Y.; Wang, F.; Song, S. X.; Guo, Y. J.; Zhou, Q.; Wang, Y.; Lin, Z. Y.; Yang, Y.; Zhang, W. D.; Sun, S. H. Expression of HBV Proteins in Transgenic Mice Disturbs Liver Lipid Metabolism and Induces Oxidative Stress. J. Hepatol. 2007, 48, 12-19.
14. Edgington, T. S.; Curtiss, L. K. Plasma lipoproteins with bioregulatory properties including the capacity to regulate lymphocyte function and the immune response. Cancer Res. 1981, 41, 3786-3788.
15. Laskowitz, D. T.; Lee, D. M.; Schmechel, D.; Staats, H. F. Altered immune responses in apolipoprotein E-deficient mice. J. Lipid Res. 2000, 41, 613-620.
16. Vitale, J. J.; Broitman, S. A. Lipids and immune function. Cancer Res. 1981, 41, 3706-3710.
17. Williams, R. D.; Wang, E.; Merrill, A. H., Jr. Enzymology of long-chain base synthesis by liver: characterization of serine palmitoyltransferase in rat liver microsomes. Arch. Biochem. Biophys. 1984, 228, 282-291.
18. Rother, J.; van Echten, G.; Schwarzmann, G.; Sandhoff, K. Biosynthesis of sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells. Biochem. Biophys. Res. Commun. 1992, 189, 14-20.
19. Davis, H. L.; Millan, C. L.; Watkins, S. C. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther. 1997, 4, 181-188.
20. Payette, P. J.; Weeratna, R. D.; McCluskie, M. J.; Davis, H. L. Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms. Gene Ther. 2001, 8, 1395-1400.
21. Memon, R. A.; Holleran, W. M.; Moser, A. H.; Seki, T.; Uchida, Y.; Fuller, J.; Shigenaga, J. K.; Grunfeld, C.; Feingold, K. R. Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb. Vasc. Biol. 1998, 18, 1257-1265.
22. Morita, S. Y.; Kawabe, M.; Sakurai, A.; Okuhira, K.; Vertut-Doi, A.; Nakano, M.; Handa, T. Ceramide in lipid particles enhances heparan sulfate proteoglycan and low density lipoprotein receptor-related protein-mediated uptake by macrophages. J. Biol. Chem. 2004, 279, 24355-24361.
23. Rye, K. A.; Hime, N. J.; Barter, P. J. The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins. J. Biol. Chem. 1996, 271, 4243-4250.
24. Worgall, T. S.; Juliano, R. A.; Seo, T.; Deckelbaum, R. J. Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein. Arterioscler Thromb. Vasc. Biol. 2004, 24, 943-948.
25. Xu, X. X.; Tabas, I. Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. J. Biol. Chem. 1991, 266, 24849-24858.
26. Subbaiah, P. V.; Liu, M. Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of Lecithin-cholesterol acyltransferase reaction. J. Biol. Chem. 1993, 268, 20156-20163.
27. Bolin, D. J.; Jonas, A. Sphingomyelin inhibits the Lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J. Biol. Chem. 1996, 271, 19152-19158.
28. Chalfant, C. E.; Spiegel, S. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J. Cell Sci. 2005, 118, 4605-4612.
29. Van Brocklyn, J. R.; Graler, M. H.; Bernhardt, G.; Hobson, J. P.; Lipp, M.; Spiegel, S. Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood 2000, 95, 2624-2629.
30. Adam, D.; Heinrich, M.; Kabelitz, D.; Schutze, S. Ceramide: does it matter for T cells. Trends Immunol. 2002, 23, 1-4.
31. Gomez-Munoz, A.; Kong, J.; Salh, B.; Steinbrecher, U. P. Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. FEBS Lett. 2003, 539, 56-60.
32. Olivera, A.; Rivera, J. Sphingolipids and the balancing of immune cell function: lessons from the mast cell. J. Immunol. 2005, 174, 1153-1158.
33. Yopp, A. C.; Randolph, G. J.; Bromberg, J. S. Leukotrienes, sphingolipids, and leukocyte trafficking. J. Immunol. 2003, 171, 5-10.